The POM monoclonals: a comprehensive set of antibodies to non-overlapping prion protein epitopes.
about
The strain-encoded relationship between PrP replication, stability and processing in neurons is predictive of the incubation period of diseaseNeurodegeneration and unfolded-protein response in mice expressing a membrane-tethered flexible tail of PrPPrion pathogenesis in the absence of NLRP3/ASC inflammasomesPrion protein-specific antibodies that detect multiple TSE agents with high sensitivityIntraperitoneal Infection of Wild-Type Mice with Synthetically Generated Mammalian PrionThe crystal structure of an octapeptide repeat of the Prion protein in complex with a Fab fragment of the POM2 antibodyThe toxicity of antiprion antibodies is mediated by the flexible tail of the prion proteinThe octarepeat region of the prion protein is conformationally altered in PrP(Sc)Biochemical properties of highly neuroinvasive prion strainsDefining the conformational features of anchorless, poorly neuroinvasive prionsThe prion protein is an agonistic ligand of the G protein-coupled receptor Adgrg6Tetracysteine-tagged prion protein allows discrimination between the native and converted formsPost-translational modifications in PrP expand the conformational diversity of prions in vivoGlobular domain of the prion protein needs to be unlocked by domain swapping to support prion protein conversionHuman prion protein sequence elements impede cross-species chronic wasting disease transmission.Functionally relevant domains of the prion protein identified in vivoRepetitive immunization enhances the susceptibility of mice to peripherally administered prions.Unexpected tolerance of alpha-cleavage of the prion protein to sequence variationsEnhanced neuroinvasion by smaller, soluble prions.Liposome-siRNA-peptide complexes cross the blood-brain barrier and significantly decrease PrP on neuronal cells and PrP in infected cell cultures.A proposed mechanism for the promotion of prion conversion involving a strictly conserved tyrosine residue in the β2-α2 loop of PrPC.Experimental verification of a traceback phenomenon in prion infection.The N-terminus of the prion protein is a toxic effector regulated by the C-terminus.Dynamic diagnosis of familial prion diseases supports the β2-α2 loop as a universal interference target.PrP(Sc)-specific antibodies with the ability to immunodetect prion oligomers.Engulfment of cerebral apoptotic bodies controls the course of prion disease in a mouse strain-dependent manner.Prion strain interactions are highly selective.Prion protein and Abeta-related synaptic toxicity impairment.Comparison of 2 synthetically generated recombinant prions.Lymphotoxin, but not TNF, is required for prion invasion of lymph nodes.Prion protein-specific antibodies-development, modes of action and therapeutics applicationPrion pathogenesis is faithfully reproduced in cerebellar organotypic slice cultures.The role of the NADPH oxidase NOX2 in prion pathogenesis.Biological effects and use of PrPSc- and PrP-specific antibodies generated by immunization with purified full-length native mouse prions.The sheddase ADAM10 is a potent modulator of prion disease.Characterization of four new monoclonal antibodies against the distal N-terminal region of PrP(c).Single-molecule imaging reveals that small amyloid-β1-42 oligomers interact with the cellular prion protein (PrP(C))Spongiform encephalopathy in transgenic mice expressing a point mutation in the β2-α2 loop of the prion protein.Crystallization and preliminary X-ray diffraction analysis of prion protein bound to the Fab fragment of the POM1 antibodyPrion infections and anti-PrP antibodies trigger converging neurotoxic pathways.
P2860
Q27312083-6ACCBEE3-8F51-45C8-99FC-60959BCF9208Q27316068-6DC2CB45-0FF3-45AB-95CA-77E54F1208D5Q27316552-626A863D-D4EE-4BDA-98F1-1F50F8942402Q27316704-79B40A67-610A-4498-BBA3-CE4ADF4C840DQ27319284-0F774A6C-A44A-4664-97EF-AD1A879BAC31Q27677854-3FB8AD0C-3A36-4C34-A99D-AB09025CFC16Q27685314-29263D23-E10D-45EA-A88A-F505DAB2B19FQ28473010-8A06908A-AA80-40AF-A994-361F0B4CF4B6Q28480480-0193E4E4-60C5-4FB4-ACD2-245BE231F45EQ28486278-30041775-6E91-4932-B705-2EF9E67248DAQ28511844-8A2F0EA1-7706-4BB0-BCAB-50318899F004Q28592095-A8C00B4D-A197-4288-BA89-42576E998839Q30399619-8C3EE57E-DCE8-4F12-8FA5-678B2CCD08D1Q30468679-5F137D5B-AFB7-4590-90A2-2F6831D02AB8Q30639674-A7D7220B-9833-478E-9CD1-B011B48F4411Q33501189-EAFF5680-39D3-44C9-8D63-6E9E9D6EB87AQ33506629-16C23227-84F7-44F0-938A-3091DBC09735Q33531737-F5A17EF7-E474-4B3E-8B5A-60AC79720545Q33588967-400D39B2-C4BE-4972-AFF1-103988B31FE0Q33608651-2CA0F2E4-C299-4D01-8BE6-3D0AE4FBF1D5Q33675812-4D45EA6B-DD22-4CA1-A39F-5E9AE1CCAC72Q33725612-9C3EE1A7-66D3-4FB4-ACF2-E7A8282147BCQ33793628-578AE518-AB81-4B2B-8669-E7B786FD5A85Q33892707-356E1A30-EEBE-4948-A4EE-1EF5A82C9642Q33916451-10E5CF42-C2C7-453D-B53D-D56A2AD3C9D4Q34161546-44943BA9-078E-40BA-9648-5C0D2C20A44CQ34185289-90465936-F010-4D89-A974-38102C0F3EA6Q34233877-7C47F91C-08CB-4429-8C0C-8C678127590DQ34307252-BEFD55FE-95CC-4AE6-B7EF-44554FD5F4F0Q34388480-6B101375-6601-4B68-A058-E4162EDD41BCQ34423386-1BEDF1F4-5CEA-447D-A99D-685EAA35D7A7Q34468979-1336E26C-26C1-4713-93E9-813B9A6F7051Q34682177-C3150E82-7E02-46E5-91B0-C826FF205C8AQ35076872-18D55D1E-10D0-461B-9175-2EEF7D31D6B5Q35137829-716BA651-181A-4768-97F5-E687D92F0950Q35205070-16093C63-C4AD-433B-89E3-E767054523CEQ35211687-DE22DC3D-85A2-4F95-B28C-B215E8228C4FQ35499036-8A8A5DAB-9BA4-4E5D-BD00-0262BE4A4FC3Q35539075-B050F9DA-F4FC-4AF2-9DFF-8A95B5CBE141Q35566835-F16DA432-A8B6-4679-A408-9F8322D6261E
P2860
The POM monoclonals: a comprehensive set of antibodies to non-overlapping prion protein epitopes.
description
2008 nî lūn-bûn
@nan
2008 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2008 թվականի դեկտեմբերին հրատարակված գիտական հոդված
@hy
2008年の論文
@ja
2008年学术文章
@wuu
2008年学术文章
@zh-cn
2008年学术文章
@zh-hans
2008年学术文章
@zh-my
2008年学术文章
@zh-sg
2008年學術文章
@yue
name
The POM monoclonals: a compreh ...... apping prion protein epitopes.
@ast
The POM monoclonals: a compreh ...... apping prion protein epitopes.
@en
type
label
The POM monoclonals: a compreh ...... apping prion protein epitopes.
@ast
The POM monoclonals: a compreh ...... apping prion protein epitopes.
@en
prefLabel
The POM monoclonals: a compreh ...... apping prion protein epitopes.
@ast
The POM monoclonals: a compreh ...... apping prion protein epitopes.
@en
P2093
P2860
P50
P1433
P1476
The POM monoclonals: a compreh ...... apping prion protein epitopes.
@en
P2093
Anne Bellon
Bill Yajima
Christina Sigurdson
Graciela Garen
Iva Hafner-Bratkovic
Magdalini Polymenidou
Martin Vey
Michael N G James
Mike Scott
P2860
P356
10.1371/JOURNAL.PONE.0003872
P407
P577
2008-12-08T00:00:00Z